-
November 1: The Week in Cancer News
Another drug shows preliminary signs of efficacy in treating patients with KRAS-mutated cancer, and a study indicates that minority cancer patients struggle to find doctors who share or understand their culture.
by Kate Yandell
-
Learning the Language of Chemotherapy
Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.
by Jen Tota McGivney
-
Navigating Hospital Discharge Decisions
Patients with advanced cancer often go to rehabilitation facilities after a hospital stay in hopes of gaining the strength for further treatment, but the majority do not go on to receive additional cancer therapy, a study reports.
by Ashley P. Taylor
-
October 25: The Week in Cancer News
A physician writes about her experiences treating patients with CAR-T cell therapy, and the U.S. Food and Drug Administration expands approval of an ovarian cancer drug based on a new biomarker.
by Kate Yandell
-
October 18: The Week in Cancer News
A chemotherapy drug used to treat childhood cancer is in short supply, and organizations update exercise recommendations for people who have been diagnosed with cancer.
by Kate Yandell
-
Misunderstandings About Cancer DNA Tests
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
-
October 11: The Week in Cancer News
A researcher with melanoma writes about his experiences trying to modify his gut microbiome, and an article discusses what it means to call a cancer treatment “well tolerated.”
by Kate Yandell
-
Cancer Patients Should Receive Flu Shots
People with cancer are at increased risk of serious complications if they get the flu. Flu shots are safe for this group, and a recent study bolsters evidence of their effectiveness.
by Carly Weeks
-
October 4: The Week in Cancer News
More than half of patients with advanced melanoma who took an immunotherapy combination were alive five years later, and a targeted therapy appears to cause high blood pressure.
by Kate Yandell
-
First Ladies of Africa Issue Call to Address Cancer Crisis
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
Cancer Talk
Treatment Combination Improves Survival in EGFR-positive Lung Cancer
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
